AbbVie

AbbVie is a leading biotech company specializing in the research, development, and manufacturing of pharmaceuticals, biologics, and medical devices. The company's primary focus lies in discovering innovative treatments for diseases such as cancer, immune-mediated disorders, neurological conditions, and chronic kidney disease.

Established in 2013 as a spinoff from Abbott Laboratories, AbbVie has experienced remarkable growth and established itself as a prominent player in the biotech industry.

AbbVie's product portfolio includes globally renowned medications, with Humira being a standout treatment for autoimmune conditions like rheumatoid arthritis, psoriasis, and Crohn's disease. Additionally, the company maintains a robust pipeline of new medications under development, targeting various ailments.

As of May 2023, AbbVie demonstrates financial success, with a market valuation of approximately $190 billion. In 2022, the company achieved a revenue of $59.7 billion, resulting in a net profit of $13.6 billion.

AbbVie is committed to corporate citizenship, prioritizing sustainability, social responsibility, and ethical business practices. The company actively engages in charitable initiatives, with a particular focus on improving access to healthcare and education.

Recognized as an exceptional employer, AbbVie has been named one of the top biotech firms to work for. The organization values diversity, inclusivity, and teamwork, offering its employees opportunities for personal and professional growth.

Founded: 2013
Headquarters: North Chicago, Illinois, U.S.
Website: https://www.abbvie.com/